Loop-mediated Isothermal Amplification Market : Global Industry Analysis and Opportunity Assessment, 2035

Loop-Mediated Isothermal Amplification Market Size, Market Forecast and Outlook By FMI

The loop-mediated isothermal amplification market was valued at USD 115.7 million in 2025 and is projected to attain USD 184.8 million by 2035. The market is expected to register a 4.9% CAGR during the forecast period. Microfluidic technology led the technology segment with a 63.8% share in 2025, while clinical diagnostics accounted for 63.8% share of the application segment.

Summary of the Loop-mediated Isothermal Amplification Market

• Demand and Growth Drivers
  • Point-of-care testing is expected to increase LAMP use across clinical and field diagnostic settings.
  • Infectious disease screening is likely to keep LAMP relevant where fast nucleic acid detection is required.
  • Healthcare research funding is anticipated to support wider use of affordable molecular testing tools.
• Product and Segment View
  • Microfluidic technology is expected to remain the leading technology due to compact assay integration.
  • Clinical diagnostics are likely to stay central as hospitals and diagnostic centers require rapid test output.
  • Kits and reagents are anticipated to gain steady use as LAMP testing expands in routine laboratory workflows.
• Geography and Competitive Outlook
  • India is expected to lead country-level expansion as healthcare research and clinical diagnostics advance.
  • Spain is likely to record strong uptake as healthcare technology investment improves molecular testing use.
  • Companies with stronger diagnostic kits and research partnerships are anticipated to improve market access.
• Analyst Opinion
  • Sabyasachi Ghosh, Principal consultant for Healthcare at FMI, suggests, “The loop-mediated isothermal amplification market is likely to gain from rapid diagnostics and field-ready molecular testing. Companies with stronger kit design and easier workflow integration are expected to gain advantage as healthcare providers seek faster results without complex equipment.”
• Loop-mediated Isothermal Amplification Market Value Analysis
  • The loop-mediated isothermal amplification market remains linked to the need for rapid and affordable diagnostics.
  • LAMP adoption is likely to rise as point-of-care testing becomes more common in clinical settings.
  • Diagnostic providers are anticipated to use LAMP where simple workflows and faster results are needed.
  • Market participants are expected to benefit from kit development and wider research collaboration.

Analyzing Loop-Mediated Isothermal Amplification Market by Top Investment Segments

The global loop-mediated isothermal amplification (LAMP) market is expected to experience significant growth from 2025 to 2035. Key segments contributing to this growth include microfluidic technology and clinical diagnostics. These segments are driven by the increasing demand for rapid, cost-effective, and precise diagnostic solutions, particularly in infectious disease testing and point-of-care applications.

Microfluidic Technology to Lead the Market with Enhanced Diagnostic Precision

Microfluidic technology is expected to account for 63.8% of the loop-mediated isothermal amplification market share in 2025. This segment is seeing significant growth due to the increasing use of microfluidic systems in LAMP-based assays, which offer high precision and efficiency in nucleic acid amplification.

Microfluidic platforms enable the integration of multiple processes, such as sample preparation, amplification, and detection, into a single, compact device. These devices are highly valued for their ability to provide rapid results, reduced reagent consumption, and portability, making them ideal for field diagnostics and point-of-care settings.

Key players such as Thermo Fisher Scientific and Abbott are advancing microfluidic technologies by developing compact, easy-to-use platforms that integrate LAMP with real-time detection. The application of microfluidics in LAMP systems is also expanding into various sectors, including environmental monitoring, food safety, and veterinary diagnostics. As the demand for faster and more efficient diagnostic tools increases, microfluidic technology is expected to continue its dominance in the LAMP market, driving its growth in both developed and emerging markets.

Clinical Diagnostics Segment to Drive Growth with Increasing Demand for Point-of-Care Testing

The clinical diagnostics segment is projected to hold 63.8% of the LAMP market share in 2025. This growth is driven by the rising demand for rapid, accurate, and affordable diagnostic tests for infectious diseases, particularly in resource-limited settings. LAMP is gaining popularity in clinical diagnostics due to its ability to amplify DNA or RNA without the need for thermal cycling, making it well-suited for use in point-of-care (POC) settings and in-field applications.

The clinical diagnostics market is expanding due to the increasing prevalence of infectious diseases such as COVID-19, malaria, and tuberculosis, which require fast and accurate diagnostic tools. The ease of use, affordability, and rapid results offered by LAMP technology are making it an attractive option for healthcare providers, especially in rural or underserved regions.

Companies like Bio-Rad Laboratories and Eiken Chemical are at the forefront of developing LAMP-based diagnostic kits and systems designed to provide reliable results in a wide range of healthcare settings. As the need for timely diagnostics continues to grow, the clinical diagnostics segment is expected to be a significant driver of growth in the LAMP market.

Loop-mediated Isothermal Amplification Market Analysis

• Government initiatives related to genetic testing and DNA research encourage more LAMP procedures.
• With the rising threat of infectious diseases, LAMP is one procedure that is being invested into to aid in the identification of these diseases in individuals.
• LAMP is preferred to polymerase chain reaction (PCR) by certain researchers and medical professionals because of its rugged quality and lower sensitivity to inhibitors than PCR.

Loop-mediated Isothermal Amplification Market Trends

• Because of the low cost of the procedure, LAMP is emerging as a viable testing and diagnostic measure in developing and underdeveloped countries.
• LAMP is used not just for diagnosis and blood-related procedures but also for identifying bodily fluids.
• LAMP’s coupling with technology has yielded results for researchers, and thus, the infusion of technology is expected to keep the market outlook fresh.
• LAMP procedures are being combined with leading molecular approaches such as real-time detection and chip-based assays for improved performance.
• PCR is a major competitor to LAMP and is still the primary blood-testing procedure. The popularity of PCR constrains the growth of the market.
• LAMP lacks the versatility of PCR, which can be used for cloning and other blood-related procedures. Thus, LAMP’s rigid application serves to impede the progress of the market.
• LAMP as a procedure is still a developing science, and thus, the market suffers from a lack of awareness on the part of end-users.

Country-wise Analysis

The Asia Pacific is emerging as a hub for healthcare research, thus aiding the loop-mediated isothermal amplification’s cause in the region. The growing incidence of genetic disorders in the region is also positively affecting the market in the Asia Pacific.

Europe being at the forefront of healthcare technology is proving conducive to the market’s progress in the region. The European Union’s initiatives to control the spread of newer diseases is also helping the market’s cause in Europe.

Countries	CAGR (2025 to 2035)
China	5.3%
India	6.2%
United Kingdom	4.7%
Spain	5.6%
Italy	4.9%

Initiatives to Inculcate Research Studies Further into the Medical Field Propelling the Market in India

The market is anticipated to register a CAGR of 6.2% in India for the forecast period. Some of the factors driving the growth of the market in the country are:

• Government initiatives aiding research in India are helping along the market. Clinical diagnostics and other research-related fields are advancing rapidly in India and playing a more pivotal role in the healthcare sector. Thus, LAMP procedures are progressing along in the country.
• There is encouragement in India for research from all corners, from high-end companies to university level, and thus the market has wide scope in the country.

Widespread Use of LAMP in Virus-relate Disease Testing in the United Kingdom

The United Kingdom is set to see the market expand at a CAGR of 4.7% over the forecast period. Prominent factors driving the growth of the market are:

• Research institutions in the United Kingdom are taking the help of LAMP to produce diagnosis solutions for virus-related diseases like SARS and COVID-19.
• University-level research is being encouraged in the medical field in the United Kingdom. Bath University is one such university that has used LAMP to come up with new diagnostic capabilities.

China’s Robust Healthcare Sector Conducive to the Growth of the Market in the Country

The market is expected to register a CAGR of 5.3% in China during the forecast period. Some of the factors driving the growth of the market in China are:

• China’s humongous population necessitates the presence of an effective healthcare system. The healthcare system in China is fledging, and thus, research procedures like LAMP have an easy pathway in the country.
• China has been under the threat of developing new diseases in the recent past. Thus, procedures that help in the identification and research of these diseases, such as LAMP, are increasing in popularity in the country.

Increasing Investment in Healthcare Technology Leading to Market Acceleration in Spain

The market is set to progress at a CAGR of 5.6% in Spain during the forecast period. Factors influencing the growth of the market in Spain include:

• Both public and private investment in healthcare technology is growing in Spain, and thus, LAMP is finding an easy pathway towards progress in the country.
• A rising number of people with genetic conditions are spurring DNA testing in Spain, and the loop-mediated isothermal amplification market is benefiting.

Public Desire to Keep Infectious Diseases at Bay Molding the Market Positively in Italy

The market is expected to register a CAGR of 4.9% in Italy. Some of the reasons for the growth of loop-mediated isothermal amplification in the country are:

• Italy’s many coastal regions expose the country’s population to several water-borne diseases. Diagnostic procedures like LAMP are being utilized in the country to keep the threat of infectious diseases controlled.
• Low cost of LAMP is helping the procedure to make further headway into Italy, where the funding for research institutions has the potential to be sketchy.

Competitive Landscape in the Loop-mediated Isothermal Amplification Market

Since loop-mediated isothermal amplification is still a developing process, the market is currently being controlled by a few reputed names. However, as the knowledge about the procedure grows, new entrants are steadily making their way into the market.

Market players are collaborating with healthcare and research institutions to eradicate the lack of awareness about the procedure. Both public and private investment are being sought by market players in their bid to develop the procedure further.

Recent Developments in the Loop-mediated Isothermal Amplification Market

• In 2023, researchers at Bath University in England developed the LoCKAmp test, described as the fastest COVID test in the world, with the help of reverse transcription loop-mediated isothermal amplification.
• Also in 2023, scientists from the University of Surrey, Brunel University London, and Lancaster University, along with the NHS, GB Electronics (UK) Ltd., and Vidiia Ltd., developed the VIDIIA Hunter (VH6) platform for infectious disease testing. It combines RT-LAMP with AI.
• In August 2022, LGC Clinical Diagnostics’ collaboration with Stanford Medicine's Department of Obstetrics and Gynecology and Metabolic Health Center was extended.

Key Companies in the Loop-mediated Isothermal Amplification Market

• Jena Bioscience GmbH
• HiberGene Diagnostics
• Meridian Bioscience, Inc.
• Mast Group Ltd.
• Excellgen, Inc.
• Merck KGaA
• QIAGEN N.V
• NIPPON GENE CO., LTD
• New England Biolabs
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific

Key Coverage in the Loop-mediated Isothermal Amplification Industry Report

• isothermal nucleic acid amplification technology market covergae
• Loop-mediated isothermal amplification (LAMP) market revenue analysis
• INAAT Market Share & Size Assessment
• LAMP Technique Coverage
• LAMP Assay Market Report
• LAMP and PCR Market Comparative Analysis

Report Scope Table - Loop-Mediated Isothermal Amplification Market

Report Attributes	Details
Current Total Market Size (2025)	USD 115.7 million
Projected Market Size (2035)	USD 184.8 million
CAGR (2025 to 2035)	4.9%
Base Year for Estimation	2024
Historical Period	2020 to 2024
Projections Period	2025 to 2035
Quantitative Units	USD million for dollar sales
Product Types Analyzed (Segment 1)	Instruments (Incubation Systems, Turbidimeters, Agarose Gel Electrophoresis, Fluorescence Measuring Systems), Kits & Reagents (DNA Polymerase, Primer Mix, DNA Polymerase & Primer Mix, Dyes, Other Reagents)
Technologies Analyzed (Segment 2)	Microfluidic Technology, Advanced Infrared Optical Technology, Modern Microsystem Technology
Applications Analyzed (Segment 3)	Diagnostic Purposes, Research Purposes
End-users Analyzed (Segment 4)	Hospital Laboratories, Research and Academic Institutes, Diagnostic Centers
Regions Covered	North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA)
Countries Covered	United States, Canada, Mexico, Brazil, Argentina, Germany, France, United Kingdom, Italy, Spain, Netherlands, China, India, Japan, South Korea, ANZ, GCC Countries, South Africa
Key Players influencing the Loop-Mediated Isothermal Amplification Market	Jena Bioscience GmbH, HiberGene Diagnostics, Meridian Bioscience, Inc., Mast Group Ltd., Excellgen, Inc., Merck KGaA, QIAGEN N.V, NIPPON GENE CO., LTD, New England Biolabs, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific
Additional Attributes	dollar sales, CAGR trends, product type segmentation, technology adoption, application-based demand, end-user distribution, competitor dollar sales & market share, regional growth trends

Key Segments

By Product:

• Instruments
  • Incubation Systems
  • Turbidimeters
  • Agarose Gel Electrophoresis
  • Fluorescence Measuring Systems
• Kits & Reagents
  • DNA Polymerase
  • Primer Mix
  • DNA Polymerase & Primer Mix
  • Dyes
  • Other Reagents

By Technology:

• Microfluidic Technology
• Advanced Infrared Optical Technology
• Modern Microsystem Technology

By Application:

• Diagnostic Purposes
• Research Purposes

By End User:

• Hospital Laboratories
• Research and Academic Institutes
• Diagnostic Centers

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)